These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30056470)

  • 1. Dihydrolipoamide dehydrogenase suppression induces human tau phosphorylation by increasing whole body glucose levels in a C. elegans model of Alzheimer's Disease.
    Ahmad W
    Exp Brain Res; 2018 Nov; 236(11):2857-2866. PubMed ID: 30056470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Methoxyindole-2-carboxylic acid (MICA) suppresses Aβ-mediated pathology in C. elegans.
    Ahmad W; Ebert PR
    Exp Gerontol; 2018 Jul; 108():215-225. PubMed ID: 29709515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
    Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
    Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.
    Planel E; Miyasaka T; Launey T; Chui DH; Tanemura K; Sato S; Murayama O; Ishiguro K; Tatebayashi Y; Takashima A
    J Neurosci; 2004 Mar; 24(10):2401-11. PubMed ID: 15014115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau.
    Brandt R; Gergou A; Wacker I; Fath T; Hutter H
    Neurobiol Aging; 2009 Jan; 30(1):22-33. PubMed ID: 17590239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase (
    Ahmad W; Ebert PR
    Genes Dis; 2021 Nov; 8(6):849-866. PubMed ID: 34522713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
    Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
    Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration.
    Wang JZ; Wang ZH
    Exp Gerontol; 2015 Aug; 68():82-6. PubMed ID: 25777063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
    Wang C; Saar V; Leung KL; Chen L; Wong G
    Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
    Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
    Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.
    Arendt T; Stieler J; Holzer M
    J Neural Transm (Vienna); 2015 Apr; 122(4):531-9. PubMed ID: 25480630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease.
    Wang G; Huang Y; Wang LL; Zhang YF; Xu J; Zhou Y; Lourenco GF; Zhang B; Wang Y; Ren RJ; Halliday GM; Chen SD
    Sci Rep; 2016 May; 6():26697. PubMed ID: 27221467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule destruction induces tau liberation and its subsequent phosphorylation.
    Miyasaka T; Sato S; Tatebayashi Y; Takashima A
    FEBS Lett; 2010 Jul; 584(14):3227-32. PubMed ID: 20561519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.
    Ando K; Oka M; Ohtake Y; Hayashishita M; Shimizu S; Hisanaga S; Iijima KM
    Biochem Biophys Res Commun; 2016 Sep; 478(2):929-34. PubMed ID: 27520376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease.
    Gratuze M; El Khoury NB; Turgeon A; Julien C; Marcouiller F; Morin F; Whittington RA; Marette A; Calon F; Planel E
    Neurobiol Dis; 2017 Feb; 98():1-8. PubMed ID: 27793638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichloroacetate and thiamine improve survival and mitochondrial stress in a C. elegans model of dihydrolipoamide dehydrogenase deficiency.
    Broxton CN; Kaur P; Lavorato M; Ganesh S; Xiao R; Mathew ND; Nakamaru-Ogiso E; Anderson VE; Falk MJ
    JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36278487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.